HHealthcare Read More Trump low-cost GLP-1 plan a likely boost for Eli Lilly, Novo NordiskJune 30, 2026 WASHINGTON — The Trump administration’s grand bargain with drugmakers on GLP-1s was based on a simple premise: lower…